Oncoype DX test

Hi everyone
Posted before that have been recently diagnosed and will be going on AS. As I have never had any long term medical situation this kind of thing is new to me. Am otherwise healthy
So had an oncotype Dx test done. and am curious about others experience with this test. In particular what do the following mean that's listed in the report

adverse pathology-16%
high grade disease-10%
non organ confined disease-8%

the score was 31(very low risk)

My original URO who did this gave me no explanation(I am with someone else now and have an apt 10-5.

Any additional comment regarding this test would be helpful

Thanks much

bump

I wish I knew something on this test, but I don't. I haven't had it. Looking at your other factors, I'd still put you in the low risk group and fine for AS.

I found one article from a few years ago on this that might be interesting:

/prostatecancerinfolink.net/2013/06/06/the-real-clinical-utility-of-tests-like-prolaris-and-oncotype-dx-in-management-of-prostate-cancer/

Andrew

Pratoman-thanks for the info, If I read you right then this test is predicting the chances of higher grade disease, adverse pathology, or non organ confined disease from this one sample. In which case the MRI is a better measure of that.
Or does it estimate the likelihood that these conditions will evolve.

Is this a useful/meaningful test??
Again thanks for the info

mufjem said...
Pratoman-thanks for the info, If I read you right then this test is predicting the chances of higher grade disease, adverse pathology, or non organ confined disease from this one sample. In which case the MRI is a better measure of that.
Or does it estimate the likelihood that these conditions will evolve.

Is this a useful/meaningful test??
Again thanks for the info

It estimates the chance of these conditions existing, AS I INDERSTAND IT. An MRI would be useful but is not foolproof, neither are the tests. But they are a good guesstimate of what MIGHT be the case or what MIGHT evolve.

I THINK, there is always a chance that a biopsy missed some tumor 9th Different genomics. Others might be better educated to address that issue

My wife had the Oncotype Breast Cancer Recurrance test in 2010 and it showed a 23% probability or recurrance within seven years without using chemotherapy. Coupled with all the other testing of the tumor biology and physical evidence from the specimen and lymph nodes it helped her medical oncologist to include chemo in the treatment mix. At that time BC was their only test and there were about 50,000 cases in their database.

As was stated, this is a data point, not a predictor nor confirmation of anything.